Sign in
CompletedNo phase

Magnetic Resonance-Guided Laser Interstitial Thermal Therapy for Brain Metastases Trial

Key facts

Who runs it
Beijing Tiantan Hospital
Where
China6 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
98 people enrolled
Started
11 Jan 2022
Ended
11 Jun 2025
Type of study
Interventional
Treatments tested
  • Laser interstitial thermal therapy
Record updated
20 August 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Age 18 years and above
  • Previously diagnosed or newly diagnosed with a malignant tumor in the body accompanied by intracranial metastasis
  • The lesion can be clearly identified in the magnetic resonance imaging, and the number of lesions does not exceed 4
  • The lesion to be treated by ablation has a short axis of ≤ 30mm
  • Karnofsky Performance Status (KPS) score ≥ 60
  • The subject or their guardian can understand the purpose of the trial, demonstrate sufficient compliance with the trial protocol, and sign the informed consent form

Who cannot take part

  • Subjects who have participated in any clinical trials of drugs or medical devices within 3 months before screening
  • Patients judged by the researcher to have evidence of severe or uncontrollable systemic diseases
  • Patients with contraindications for MRI
  • Patients with severe coagulation dysfunction
  • Pregnant or lactating women, and those planning to conceive within 6 months
  • Patients with the longest axis of the maximum brain metastasis lesion less than 5mm
  • Patients judged by the researcher to be unable to tolerate ablation treatment
  • Subjects considered by the researcher to be unsuitable for this clinical trial

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

In accordance with the requirements of the "Good Clinical Practice for Medical Devices", this clinical trial is conducted to further evaluate the safety and efficacy of the magnetic resonance-guided laser ablation treatment system and the laser ablation minimally invasive treatment kit produced by Sinovation (Beijing) Medical Technology. This clinical trial adopts a multi-center, single-groupdesign. After all subjects sign the informed consent form and pass the screening, they will receive the implantation and treatment of the trial products. Follow-up visits will be conducted on the 2±1 day after the surgery, and the efficacy rate of ablation as assessed after the surgery was used as the primary outcome.

The group in the trial

  • laser interstitial thermal therapyTreatment being tested

    The subjects will undergo laser interstitial thermotherapy after the screening process is completed. There will be no restrictions on other treatment methods.

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Multicenter Trial for the Safety and Efficacy of a Magnetic Resonance-Guided Laser Interstitial Thermal Therapy for Brain Metastases
Record updated
20 August 2025